CIK 0001671584 · Non-accelerated filer<br>Smaller reporting company
Aptevo Therapeutics Inc.
Sign in to watch- Ticker
- APVO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811567056
- Phone
- 206-838-0500
- Business address
- 2401 4TH AVE., SUITE 1050, SEATTLE, WA, 98121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-03-09 | Stromatt Scott C Chief Medical Officer and SVP | Shares withheld for taxes | −3,678 | $1.80 | $7K | 50,806 |
| 2017-03-09 | Stromatt Scott C Chief Medical Officer and SVP | Option exercise · Restricted Stock Unit | −13,902 | 176,770 | ||
| 2017-03-01 | Gross Jane A See Remarks | Option exercise | +9,140 | 25,011 | ||
| 2017-03-01 | Gross Jane A See Remarks | Shares withheld for taxes | −2,148 | $2.02 | $4K | 22,593 |
| 2017-03-01 | Gross Jane A See Remarks | Option exercise · Restricted Stock Unit | −9,140 | 108,468 | ||
| 2017-03-01 | Lamothe Jeffrey G. SVP, CFO and Treasurer | Option exercise | +7,320 | 24,386 | ||
| 2017-03-01 | Lamothe Jeffrey G. SVP, CFO and Treasurer | Shares withheld for taxes | −1,936 | $2.02 | $4K | 22,450 |
| 2017-03-01 | Lamothe Jeffrey G. SVP, CFO and Treasurer | Option exercise | +6,746 | 29,196 | ||
| 2017-03-01 | Lamothe Jeffrey G. SVP, CFO and Treasurer | Option exercise · Restricted Stock Unit | −7,320 | 72,334 | ||
| 2017-03-01 | Stromatt Scott C Chief Medical Officer and SVP | Option exercise | +16,269 | 45,894 | ||
| 2017-03-01 | Stromatt Scott C Chief Medical Officer and SVP | Shares withheld for taxes | −5,312 | $2.02 | $11K | 40,582 |
| 2017-03-01 | Stromatt Scott C Chief Medical Officer and SVP | Option exercise · Restricted Stock Unit | −16,269 | 190,672 | ||
| 2017-02-24 | White Marvin L President and CEO | Grant or award · Stock Option (right to buy) | +75,800 | 311,918 | ||
| 2017-02-24 | Stromatt Scott C Chief Medical Officer and SVP | Grant or award · Stock Option (right to buy) | +33,700 | 236,580 | ||
| 2017-02-24 | Maddux Randy Joe Senior VP, Operations | Grant or award · Stock Option (right to buy) | +33,700 | 108,700 | ||
| 2017-02-24 | Lamothe Jeffrey G. SVP, CFO and Treasurer | Grant or award · Stock Option (right to buy) | +33,700 | 142,232 | ||
| 2017-02-24 | Gross Jane A See Remarks | Grant or award · Stock Option (right to buy) | +33,700 | 156,339 | ||
| 2017-02-03 | Stromatt Scott C Chief Medical Officer and SVP | Option exercise | +27,381 | 29,625 | ||
| 2017-02-03 | Stromatt Scott C Chief Medical Officer and SVP | Option exercise · Restricted Stock Unit | −27,381 | 206,941 | ||
| 2017-02-03 | Lamothe Jeffrey G. SVP, CFO and Treasurer | Option exercise | +25,340 | 25,340 |
Page 25 of 27 · 523 trades